used in conventional Chinese, Ayurvedic, and Thai drugs. Conolidine could represent the beginning of a fresh era of Serious pain management. It is now getting investigated for its outcomes on the atypical chemokine receptor (ACK3). Within a rat model, it had been found that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3’s